Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.48% | 53.97 | 0.9% | $1408.01m | |
| JNJ | Johnson & Johnson | -0.05% | 179.54 | 0.7% | $1296.44m | |
| BMY | Bristol-Myers Squibb Co. | 0.45% | 77.59 | 1.0% | $1212.16m | |
| MRK | Merck & Co., Inc. | -1.53% | 92.32 | 0.7% | $1167.02m | |
| ABBV | AbbVie, Inc. | -0.92% | 150.56 | 1.9% | $1100.30m | |
| LLY | Eli Lilly & Co. | 2.11% | 313.48 | 1.1% | $967.28m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.29% | 142.98 | 0.0% | $491.89m | |
| AZN | AstraZeneca Plc | -0.17% | 66.70 | 1.0% | $491.50m | |
| NVS | Novartis AG | 0.01% | 91.26 | 0.2% | $259.85m | |
| GSK | GlaxoSmithKline Plc | -1.23% | 44.42 | 0.2% | $257.59m | |
| VERU | Veru, Inc. | 2.18% | 12.64 | 0.0% | $253.71m | |
| HZNP | Horizon Therapeutics Plc | 2.45% | 90.59 | 5.4% | $196.03m | |
| SGEN | Seagen Inc. | 1.46% | 138.46 | 5.7% | $185.67m | |
| NVO | Novo Nordisk A/S | 1.30% | 106.62 | 0.1% | $182.89m | |
| VTRS | Viatris, Inc. | 1.44% | 12.01 | 0.0% | $165.27m |
Company Profile
Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.